Study of a new drug for chronic kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with chronic kidney disease.
- Your urine test shows a certain level of protein (albumin-creatinine ratio between 300 and 5000 mg/g).
- Your blood potassium level is within a specific range (not too low, not too high).
- Your blood pressure is not too high (systolic between 120 and 180 mmHg).
- You are not currently on dialysis or had a kidney transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests a new daily pill (called HRS-7535) that may help protect kidney function in people with chronic kidney disease. It works like a natural hormone to help control blood sugar and reduce inflammation, and the researchers want to see if it can slow down kidney damage.
This trial tests a new medication called survodutide to see if it can reduce protein in the urine and protect kidney function in people with chronic kidney disease. It may be an option for people who already take standard blood pressure and kidney-protecting pills.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.